Evaluation of Mcl-1 Inhibitors in Preclinical Models of Multiple Myeloma

被引：2
|
作者：
Belmonte, Matthew A. [1 ]
Adam, Ammar [1 ]
Borrelli, Deanna [1 ]
Bhavsar, Deepa [1 ]
Bebernitz, Christina [1 ]
Hird, Alexander [1 ]
Secrist, Paul [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.3428.3428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
    Schneller, Anja
    Zojer, Niklas
    Bolomsky, Arnold
    Ludwig, Heinz
    HAEMATOLOGICA, 2021, 106 (09) : 2516 - 2521
  • [22] Mcl-1 inhibitors: a patent review
    Chen, Lijia
    Fletcher, Steven
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (02) : 163 - 178
  • [23] Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
    Patricia Gomez-Bougie
    Lisa Oliver
    Steven Le Gouill
    Régis Bataille
    Martine Amiot
    Oncogene, 2005, 24 : 8076 - 8079
  • [24] Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
    Gomez-Bougie, P
    Oliver, L
    Le Gouill, S
    Bataille, R
    Amiot, M
    ONCOGENE, 2005, 24 (54) : 8076 - 8079
  • [25] IL-6-independent expression of Mcl-1 in human multiple myeloma
    Zhang, B
    Potyagaylo, V
    Fenton, RG
    ONCOGENE, 2003, 22 (12) : 1848 - 1859
  • [26] IL-6-independent expression of Mcl-1 in human multiple myeloma
    Bin Zhang
    Valeria Potyagaylo
    Robert G Fenton
    Oncogene, 2003, 22 : 1848 - 1859
  • [27] INCREASING FREQUENCY OF MCL-1 mRNA EXPRESSION THROUGH THE STAGES OF MULTIPLE MYELOMA
    Mylin, A. K.
    Rasmussen, T.
    Lodahl, M.
    Dahl, I. M.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 81 - 81
  • [28] Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth
    Wang M.
    Wu D.
    Liu P.
    Deng J.
    Experimental Hematology & Oncology, 3 (1)
  • [29] Novel cyclin dependent kinase (CDK) inhibitors induce down regulation of Mcl-1 and apoptosis in multiple myeloma cells
    Maccallum, David E.
    Melville, Jean
    Watt, Kathryn
    Jackson, Wayne
    Wilson, Stuart
    McDonald, Edward
    Workman, Paul
    Green, Simon R.
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors
    Liu, Lulu
    Liu, Renshuai
    Yang, Xinying
    Hou, Xuben
    Fang, Hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191
12345